Our Products

    Our expert systems identify and prioritise promising leads and help to select drug candidates for successful drug development. IMPACT-F estimates drug-uptake in humans based on global QSAR/QSPR models and ranks candidates correctly:

    Selection of lead candidates with IMPACT-F based on predicted drug-uptake in humans (details).

MolScore-Drugs

     Expert system to identify and prioritise
                                     suitable drug candidates

MolScore-Antivirals

     Expert system to identify and prioritise
                       suitable antiviral drug candidates

MolScore-Antibiotics

     Expert system to identify and prioritise
                 suitable antibacterial drug candidates

Expert system IMPACT-F

     Oral bioavailability prediction of drug-candidates in humans

     Lead optimization & lead selection
 

    Application of customised tools derived from our ADME/Tox database improve the identification of potential risks in order to reduce clinical failures.

    MolScore-products can be combined with other predictive tools to select the most suitable drug candidates for further development, see lead selection & prioritisation.


    Looking for similar drug structures and bioavailability data related to a specific drug structure?

    Bioavailability data from similar compounds to a specific drug-candidate are very difficult to find in the literature. Without using a structure based knowledge base it is almost impossible.

    PACT-F can help to identify the most similar drugs which have been previously investigated in preclinical and clinical trials. Contact us for more information.

    Further links: Cheminformatics ADME-Software Pharmacokinetics Computational chemistry Molecular modeling
     

© Copyright 2004-2017 PharmaInformatic Boomgaarden. All rights reserved.         Site map           Contact         Terms of Use         Imprint        

 








Recent News:

Cooperation with
BRIDGE
BIORESEARCH
signed.


Bioavailability prediction of drug candidates for
treatment of Type 2 diabetes
(more)

...and in short time our development project was taken to the next step."
 



PharmaInformatic and
UNIZYME
Laboratories
sign
cooperation agreement:


Selection and prioritisation
 of lead compounds
for treatment of
inflammatory diseases
based on estimated oral bioavailability in humans with IMPACT-F.
(more)